UF Health Cancer Center member Matthew Gentry, Ph.D., was recently named a 2024 fellow of the American Society for Biochemistry and Molecular Biology (ASBMB).
Designation as a fellow recognizes outstanding commitment to the ASBMB through participation in the society, as well as accomplishments in research, education, mentorship, advocacy and service to the scientific community.
Gentry is a professor and chair of biochemistry and molecular biology in the University of Florida College of Medicine. He studies glycogen metabolism and how it goes awry in cancer and neurodegenerative disorders.
Blake Hill, a professor and chair of pharmaceutical sciences at the University of Colorado, nominated Gentry and wrote: “Throughout his career in biochemistry and molecular biology, Dr. Gentry has consistently advanced scientific knowledge, fostered collaborations, nurtured the next generation of scientists, and advocated tirelessly for our scientific community. His remarkable combination of scientific excellence, leadership acumen, and unwavering dedication to ASBMB and our broader scientific community make him an exceptionally well-suited candidate for this prestigious recognition.”
Martha S. Cyert, who was also named a 2024 fellow, also nominated Gentry and described him as an “outstanding mentor, leader and scholar on multiple fronts.”
Gentry is a member of the UF Health Cancer Center’s Mechanisms of Oncogenesis research program.
